Michele de Palma, PhD

Michele de Palma, PhD

Swiss Federal Inst. of Technology (EPFL)
Lausanne, Switzerland

Michele (Miki) De Palma heads the Angiogenesis and Tumor Microenvironment laboratory at the Swiss Federal Institute of Technology of Lausanne (EPFL), Switzerland.

Miki obtained his Ph.D. in 2004 from the University of Turin Medical School, Italy, where he studied the contribution of bone marrow-derived cells to tumor angiogenesis under the direction of Luigi Naldini. He performed post-doctoral training at the San Raffaele-Telethon Institute for Gene Therapy, Milan, to develop new gene transfer strategies for reprogramming tumor-infiltrating monocytes into anti-tumoral immune cells. He joined EPFL in 2011, where he teaches cancer biology. By employing genetic cancer models and cell-engineering strategies based on lentiviral gene transfer, the De Palma’s lab investigates the interplay among macrophages, blood vessels and T cells in tumors, primarily by focusing on angiogenic signaling, microRNA regulation, and secreted exosomes. Miki has co-organized international conferences on tumor immunology and angiogenesis, and serves on the advisory boards of several scientific journals, including Science Translational Medicine (AAAS), Cell Reports (Cell press), BBA - Reviews on Cancer, and Cancer Immunology Research (AACR). Miki received two European Research Council (ERC) grants, in 2009 and 2016. In his spare time, he studies the taxonomy of the African fruit chafers.